Metachromatic activity of β-cyclodextrin sulfates as heparin mimics

International Journal of Biological Macromolecules

Volumn 24, Issue 1, 1999, Pages 15-18

  Baumann, R ^a   Rys, P ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cyclodextrin sulfate; Heparin; Metachromatic activity

Indexed keywords

BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; HEPARIN; HYDROCORTISONE;

ANGIOGENESIS; ARTICLE; COMPLEX FORMATION; DRUG MECHANISM; GROWTH INHIBITION; SULFATION;

EID: 0032904465     PISSN: 01418130     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-8130(98)00058-0     Document Type: Article

References (34)

1. Svahn C.M., Weber M., Mattson C., Neiger K., Palm M. Carbohydr Polymers. 18:1992;9.
2. Folkman J. J Natl Cancer Inst. 82(1):1990;4.
3. Bender ML, Komiyama M, Cyclodextrin Chemistry. Berlin, 1978.
4. Shing Y., Folkman J., Weisz P.B., Joullié M.M., Ewing W.R. Anal Biochem. 185:1990;108.
5. van Boeckel C.A.A., Grootenhuis P.D.J., Haasnoot C.A.G. Trends Pharmacol Sci. 12:1991;241.
6. Weisz P.B., Joullié M.M., Hunter C.M., Kumor K.M., Zhang Z., Levine E., Macarak E., Weiner D., Barnathan E.S. Biochem Pharmacol. 54:1997;149.
7. Folkman J., Weisz P.B., Joullié M.M., Li W.W., Ewing W.R. Science. 243:1989;1490.
8. Li W.W., Casey R., Gonzalez E.M., Folkman J. Invest Ophthalmol Vis Sci. 32:1991;2898.
9. Weiner D.B., Williams W.V., Weisz P.B., Greene M.I. Pathobiology. 60:1992;206.
10. Herrmann H.C., Okada S.S., Hozakowska E., LeVeen R.F., Golden M.A., Tomaszewski J.E., Weisz P.B. et al. Arterioscler Thrombosis. 13:1993;924.
11. Okada S.S., Kuo A., Muttreja M.R., Hozakowska E., Weisz P.B., Barnathan E.S. J Pharmacol Exp Therapeutics. 273(2):1995;948.
12. Toes G.J., Barnathan E.S., Liu H., Raghunath P.N., Tomaszewski J.E., Caron R.J., Weisz P.B. et al. J Vasc Surg. 23:1996;650.
13. Weisz P.B., Kumor K., Macarak E.J. Biochem Pharmacol. 45(5):1993;1011.
14. Templeton D.M. Int J Biol Macromol. 10:1988;131.
15. Grant A.C., Linhardt R.J., Fitzgerald G.L., Park J.J., Langer R. Anal Biochem. 137:1984;25.
16. Jaques L.B., Bruce-Mitford M., Ricker A.G. Rev Canad Biol. 6:1947;740.
17. Wollin A., Jaques L.B. Thrombosis Res. 2:1973;377.
18. Weisz P.B., Hermann H.C., Joullié M.M., Kumor K., Levine E.M., Macarak E.J., Weiner D.B. Angiogenesis: Key Principles-Science-Technology-Medicine. 1992;107 Marcell Dekker, Basel.
19. Bernstein S., Joseph J.P. and Nair V. Cyclodextrin sulfate salts as complement inhibitors. US Patent 4,020,160, Patent-Appl.-604,986, 15 Aug 1975.
20. Takeo K., Uemura K., Mitoh H. J Carbohydr Chem. 7(2):1988;293.
21. Fügedi P. Carbohydr Res. 192:1989;366.
22. Rong D., D'Souza V.T. Tetrahedron Lett. 31(30):1990;4275.
23. Greene T.W., Wuts P.G.M. Protective Groups in Organic Chemistry. 1991;11 John Wiley, New York.
24. Szejtli J., Lipták A., Jodál I., Fügedi P., Nánási A., Neszmélyi A. Starch. 32(5):1980;165.
25. Takeo K., Mitho H., Uemura K. Carbohydr Res. 187:1989;203.
26. Bieg T., Szeja W. Synthesis. 1985;76.
27. Hanessian S., Liak T.J., Vanasse B. Synthesis. 1981;396.
28. Tezuka Y., Hermawan I. Carbohydr Res. 260:1994;181.
29. Baer H.H., Shen Y., González B.A.V., García J.I. Carbohydr Res. 235:1992;129.
30. Sato T., Nakamura H., Ohno Y., Endo T. Carbohydr Res. 199:1990;31.
31. McCloskey C.M. Adv Carbohydr Chem. 12:1952;137.
32. Angibeaud P., Utille J.-P. Synthesis. 9:1991;737.
33. Nakano T., Ito Y., Ogawa T. Carbohydr Res. 243:1993;43.
34. Bergeron R.J., Meeley MP, Machida Y. Bioorg Chem. 5:1976;121.